vinorelbine
Stability data issue holds up Adventrx cancer drug
March 3, 2010Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine
US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
